Scientific article
Meta-analysis
OA Policy
English

Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

Published inThe Journal of Infectious Diseases, vol. 221, no. 3, p. 356-366
Publication date2020
Abstract

The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.

Keywords
  • IPD meta-analysis
  • Neuraminidase inhibitors
  • Antivirals
  • Length of stay
  • Pandemic influenza
  • Adolescent
  • Adrenal Cortex Hormones/therapeutic use
  • Adult
  • Aged
  • Anti-Bacterial Agents/therapeutic use
  • Antiviral Agents/therapeutic use
  • Child
  • Enzyme Inhibitors/pharmacology/therapeutic use
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype
  • Influenza, Human/drug therapy/epidemiology
  • Length of Stay
  • Male
  • Middle Aged
  • Neuraminidase/antagonists & inhibitors
  • Pandemics
  • Treatment Outcome
  • Young Adult
Citation (ISO format)
VENKATESAN, Sudhir et al. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. In: The Journal of Infectious Diseases, 2020, vol. 221, n° 3, p. 356–366. doi: 10.1093/infdis/jiz152
Main files (1)
Article (Published version)
Identifiers
Journal ISSN0022-1899
248views
146downloads

Technical informations

Creation26/04/2021 10:57:00
First validation26/04/2021 10:57:00
Update time16/03/2023 00:35:55
Status update16/03/2023 00:35:50
Last indexation31/10/2024 22:06:52
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack